Declawing banned in Madison, Wisc.December 8, 2021Declawing has officially been banned in Wisconsin’s capital city.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
Declawing banned in AustinMarch 15, 2021Austin, Tex., is officially the Lone Star State’s first city to ban the declawing of cats.
Declawing banned in St. LouisDecember 16, 2019St. Louis, Mo., is officially the first Midwestern city to ban the declawing of cats.
College of Veterinarians of British Columbia bans onychectomyJune 14, 2018The College of Veterinarians of British Columbia (CVBC) has banned the practice of partial digital amputation, also known as onychectomy or declawing, of domestic cats, effective immediately. The province is the second in Canada to ban declawing, following the procedure's condemnation from the Canadian Veterinary Medical Association (CVMA). "Elective and nontherapeutic declawing is ethically problematic and not an appropriate means of dealing with feline behavior issues," reads CVBC's statement. The college acknowledges there are medical conditions that may necessitate partial or full digital amputation as an appropriate medical therapy, such as biopsy for diagnosis, severe trauma, or medical conditions affecting the health of the nail (i.e. onychodystrophy, paronychia, neoplasia of the nail bed/phalanges), but adds there is no medical condition or environmental circumstance of the cat's owner that would justify declawing. Declawing has already been banned in the United Kingdom, Europe, Australia, and several cities in California. Earlier this year, Nova Scotia became the first Canadian province to ban the procedure, with the Nova Scotia Veterinary Medical Association amending its code of ethics to declare the practice, when performed electively, "ethically unacceptable." While CVMA does not regulate veterinarians in Canada and cannot enforce a nationwide ban, the association announced …
Aratana Therapeutics seeks feline label expansion for NocitaJune 12, 2018Aratana Therapeutics Inc. announced it has submitted a supplemental new animal drug application with the FDA to approve the use of Nocita in cats to provide regional analgesia following onychectomy. Nocita (bupivacaine liposome injectable suspension), which provides up to 72 hours of analgesia postoperatively using multivesicular liposomal technology, was first approved in August 2016 for canine use following cranial cruciate ligament surgery. "We believe veterinarians are in need of safe and effective, nonopioid alternatives to provide pain relief to their feline and canine patients," said Ernst Heinen, DVM, Ph.D., chief development officer of Aratana Therapeutics. "If the supplemental NADA is approved, NOCITA will help control feline pain for up to 72 hours by blocking pain signals at their source, the nerve." Visit aratana.com.
